| Republic of Korea | Turkey | Austria | |
| Radiation therapy for ovarian cancer | - | from $12,050 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Radiation therapy for ovarian cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Radiation therapy for ovarian cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Radiation therapy for ovarian cancer journey.
Day 1
Day 2
Day 3
Week 1-6
Week 7
Week 8-10
Week 11-12
Week 13
Week 16-20
Please note each individual"s recovery process may vary.
Dr. Paik Nam-sun is a world-renowned surgeon in the field of breast cancer, thyroid cancer, and surgical oncology. He is the first in South Korea to have successfully performed the breast conserving surgery and has authored a unique stomach cancer surgery that reduces the risk of gastroesophageal reflux disease. He is an expert in the diagnosis and management of breast cancer and a member of the Korean Society of Cancer Prevention and the Korean Cancer Association.
Radiation therapy is not a standard primary treatment for ovarian cancer in South Korea. Following Korean Society of Gynecologic Oncology guidelines, practitioners prioritize primary debulking surgery and platinum-based adjuvant chemotherapy. Specialized centers like Severance Hospital reserve radiation for localized recurrences, palliative care, or chemo-resistant clear cell carcinomas.
Bookimed Expert Insight: While chemotherapy is the global standard, Korea's top-tier hospitals like Asan Medical Center and Severance Hospital differentiate themselves through extreme patient volumes. Severance alone manages 1.6 million outpatients annually. This high intensity allows Korean multidisciplinary teams to refine radiation protocols for rare, chemo-resistant subtypes that smaller international centers rarely see.
Patient Consensus: Patients report that radiation is rarely discussed during initial consultations, as the primary focus remains on genetic testing and aggressive surgical removal. Most expect a treatment plan centered on 1 to 2 nights of hospitalization for surgical recovery followed by strictly monitored chemotherapy cycles.